Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Receivables (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Receivables for 16 consecutive years, with $25.5 million as the latest value for Q3 2025.

  • Quarterly Receivables rose 24.2% to $25.5 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $25.5 million through Sep 2025, up 24.2% year-over-year, with the annual reading at $20.7 million for FY2024, 4.79% down from the prior year.
  • Receivables for Q3 2025 was $25.5 million at Xtant Medical Holdings, down from $27.0 million in the prior quarter.
  • The five-year high for Receivables was $27.0 million in Q2 2025, with the low at $6.3 million in Q3 2021.
  • Average Receivables over 5 years is $15.3 million, with a median of $13.7 million recorded in 2023.
  • The sharpest move saw Receivables fell 27.88% in 2021, then soared 99.94% in 2023.
  • Over 5 years, Receivables stood at $7.2 million in 2021, then skyrocketed by 51.71% to $10.9 million in 2022, then skyrocketed by 99.94% to $21.7 million in 2023, then dropped by 4.79% to $20.7 million in 2024, then increased by 23.51% to $25.5 million in 2025.
  • According to Business Quant data, Receivables over the past three periods came in at $25.5 million, $27.0 million, and $23.5 million for Q3 2025, Q2 2025, and Q1 2025 respectively.